Using a bioengineered tissue to treat cleft palate in children
Official title: Phase I-IIa, Randomized, Controlled, Open-label, Single-center Clinical Trial to Evaluate Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Patients With Cleft Palate
Run by Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental · NCT06408337 · Data updated 2026-11-12
This study is testing a new bioengineered tissue to see if it can help children with cleft palate heal better than the usual surgery.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 10 Months to 14 Months |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental Academic / other |
| Locations | 1 site (Granada, Spain/Granada) |
| Status | Recruiting |
| Started | April 17, 2024 |
| Main results expected | April 17, 2028 |
| Study ends | December 17, 2028 |
| Registry record updated | May 10, 2024 |
| Trial ID | NCT06408337 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pediatric patients diagnosed with total unilateral non-syndromic cleft lip and palate who are scheduled for surgical correction.
✕Probably not a fit
Patients with active infections, severe systemic disorders, or other congenital malformations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the safety, feasibility, and efficacy of BIOCLEFT, a bioengineered palatal mucosa substitute, in pediatric patients with total unilateral non-syndromic cleft lip and palate. The trial consists of two phases: an initial non-randomized phase involving 5 patients followed by a randomized phase with an additional 10 patients. Participants will receive either the investigational treatment or standard surgical reconstruction, with follow-up assessments conducted over 24 months to monitor outcomes. The study aims to determine if this innovative approach can improve tissue repair and patient recovery compared to standard care.
Why it matters
Potential benefit: If successful, this treatment could enhance healing and reduce complications for children undergoing surgery for cleft palate.
How similar studies have gone: While this approach is innovative, similar studies using tissue engineering for cleft palate repair have shown promising results, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pediatric patients, of both sexes. * Diagnosis of total unilateral non-syndromic cleft lip and palate (FLPNS) that will undergo surgery for correction. * Children who have previously donated a sample of oral mucosa during the cleft lip repair procedure (cheiloplasty). * Informed consent signed by one or both parents (or legal guardian) adequately informed of the study and willing to follow the trial procedures and instructions. Exclusion Criteria: * Active infectious diseases. * Allergies or hypersensitivity to any of the components/excipients of the Investigational Product. * Severe hematological disorders/blood dyscrasias. * Severe hepatic or renal dysfunction/failure. * Serious endocrine disorders/dysfunctions. * Malignant neoplasms * Active HIV, HBV or HCV infection. * Metabolic bone diseases (Paget's disease, hypercalcemia, etc.). * Children with cleft lip and palate who present other congenital malformations that, in the opinion of the researcher, could affect the result of the study or the interpretation of the results of the study. * Any other pathology that in the opinion of the investigator should not be included in the study for other medical or social reasons.
Where it's running
-
University Hospital Virgen de las Nieves
Granada, Spain/Granada, Spain Recruiting
Study contacts
- Study coordinator: Elisa Cubiles
- Email: emontero@fibao.es
- Phone: 955048278
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Perceptions of High and Low Intensity Speech Intervention in Children with a Cleft Palate
This study looks at how providers and children with cleft palate and their parents feel about high- versus low-intensity speech therapy to see which is more acceptable and helpful.
-
Sedation options for suture removal after cleft surgery in young children
This trial tests whether intramuscular ketamine, intranasal nalbuphine, or intranasal dexmedetomidine provide faster, safer, and more comfortable sedation for children aged 6 months to 3 years during suture removal after cleft surgery.
-
Using clear aligners to expand the upper dental arch in children with cleft lip and palate
This study is testing if clear aligners can help expand the upper jaw in children aged 6-8 with cleft lip and palate.
-
Comparing speech interventions for children with cleft palate
This study is trying to find out if high or low intensity speech therapy works better for children with cleft palate by talking to the kids, their caregivers, and speech therapists about their experiences.
-
Comparing single and multiple surgeries for nasal and alveolar repairs in cleft lip and palate patients
This study is testing whether doing all the necessary nose and gum repairs in one surgery is better than spreading them out over multiple surgeries for kids with cleft lip and palate.
-
Comparing high and low intensity speech therapy for children with cleft palate
This study is testing whether more frequent speech therapy sessions help Belgian Dutch-speaking children with cleft palate improve their speech and overall quality of life better than fewer sessions over a longer time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.